Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 90 results for "aurobindo"

Aurobindo Pharma rises 2% on USFDA final nod for Esomeprazole capsules
Money Control

Aurobindo Pharma gets USFDA nod for heartburn drug

Aurobindo Pharma has received final approval from the US health regulator to manufacture Esomeprazole Magnesium delayed-release capsules, used in treatment of frequent heartburn, in the US market.In a BSE filing, Aurobindo Pharma said it "has received final ... Business Standard, 23 hours ago

61 images for aurobindo

Money Control, 1 day ago
Business Standard, 18 hours ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 2 months ago
Sify, 2 months ago
Business Standard

Fund managers take value calls on pharma

Three beaten down pharma stocks - Sun Pharmaceutical, Dr Reddy Laboratories and Aurobindo Pharma - have emerged as the top favourites among India's equity fund managers. Fund managers call it a value buying and add that in the next 1-2 years it will not only ...
 Business Standard1 day ago Major pharmaceutical stocks gain big as investors scout for value buys  Money Control1 month ago Pharma weekly wrap: Pharma stocks had tough week due to GST and pricing pressures in US  Money Control2 months ago Closing bell: Sensex rebounds after 2-day fall, Nifty ends above 10,050; IOC up 8%  Money Control2 months ago
Money Control

Market Live: Sensex, Nifty, Midcap off day#39;s highs; HPCL, BPCL, IOC erase gains

Sun Pharma rallied nearly 4 percent, followed by Dr Reddy#39;s Labs, Lupin, Reliance Industries, Tata Motors, GAIL and Aurobindo Pharm.
 Money Control1 month ago Market Live: Sensex rises over 100 pts, Nifty inches towards previous record high  Money Control1 month ago Market Live: Nifty opens above 10,100, Midcap outperforms Sensex; BPCL, IOC rally  Money Control1 month ago Closing bell: Sensex drops 266 pts, Nifty holds 9800; Midcap plunges 3%  Money Control2 months ago
Money Control

Hold Aurobindo Pharma: Prakash Gaba

Prakash Gaba of is of the view that one may hold Aurobindo Pharma.
 Money Control1 month ago Nifty likely to open flat; pick Aurobindo Pharma, ICICI Prudential: Prakash Gaba  Money Control1 month ago Crucial support for Nifty at 9700; buy Aurobindo Pharma, sell Vedanta: Prakash Gaba  Money Control1 month ago
Money Control

Buy Aurobindo Pharma; target of Rs 817: Geojit

Geojit has recommended buy rating on Aurobindo Pharma with a target price of Rs 817 in its research report dated 1 September 2017.
 Money Control1 month ago Buy Aurobindo; target of Rs 825: Axis Direct  Money Control1 month ago
Money Control

Aurobindo Pharma to widen US portfolio, enter new markets in Europe

Aurobindo said it has been following a strategy of differentiated pipeline with new launches, including injectables, ophthalmics, speciality products and controlled substances in the US market.
 Money Control1 month ago Aurobindo to widen US portfolio, enter new mkts in Europe  Business Standard1 month ago Aurobindo to widen portfolio in US, enter new European markets in 3-4 years  Business Standard1 month ago Aurobindo bets on Eastern Europe with larger product base, acquisition  Business Standard2 months ago

Aurobindo Pharma Q1 profit dips 11% at Rs 518 cr on low US sales, GST

BS ReporterHyderabad, 9 August: Hyderabad-based Aurobindo Pharma Limited has reported a 11.4 percent decline in consolidated net profit at Rs 518.5 crore for the quarter ended June, 2017 in the absence of growth from formulations business during the ...
 Business Standard2 months ago Aurobindo Pharma first-quarter profit drops 11 percent, misses estimates  Sify2 months ago Aurobindo Pharma Q1 net profit drops 11.4% to Rs 518 cr  Money Control2 months ago Aurobindo Pharma Q1 net drops 11% at Rs 519 cr on low US sales, GST  Business Standard2 months ago

US FDA issues 2 observations to Aurobindo#39;s Unit VI in Hyderabad

CNBC-TV18 has accessed the form 483 issued to Aurobindo Pharma#39;s Unit VI in Hyderabad.
 Money Control1 month ago

Nifty outlook and three trading ideas by Prabhudas Lilladher

Buy Aurobindo Pharma, Axis Bank, HCL Tech, says Vaishali Parekh of Prabhudas Liladher
 Business Standard1 month ago

The Scotsman who knows India better than many of us

"Men of the calibre of Shri Ramana Maharishi, Satya Sai Baba, Shri Aurobindo -- you don't get that level of excellence in the West. The quality of Indian saints is unmatched."Writer Bill Aitken came to India nearly 60 years ago and never returned home to Scotland. An Indian citizen since 1972, he speaks to Archana Masih about finding a religion, a country and discovering India on steam engines and motorbikes. Do read the first part of a two-part interview exclusively on
 Rediff.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less